Bal Pharma Share Price

₹ 83.45

+₹2.64 (3.27%)
1D
Last updated 03 Nov, 2026, 15:23 IST
NSE: BALPHARMA
|
Pharmaceuticals

Bal Pharma Share Price Today

As of 3 Nov 2026, Bal Pharma share price is ₹83.45. The stock opened at ₹83.60, compared to its previous close of ₹80.81. During today's trading session, Bal Pharma share price moved in the range of ₹81.10 to ₹84.45, with an average price of ₹82.78 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.00 and a high of ₹124.60. On the performance front, Bal Pharma share price has increased by 6.04% over the last six months and is down 1.99% on a year-on-year basis.

Share price over the last 1 day fell from 83.60 to 83.45, ranging between 81.10 and 83.70.
₹81.10
3.27% up today
₹84.45
1D LOW
1D HIGH

Bal Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 15.37% YoY
Latest Earning
Net Profit TrendDown by 68.33% QoQ
Latest Earning
Revenue TrendUp by 6.23% QoQ
Stock Performance
OutperformingBeat Nifty by 8.65 % in last 6 month
Shareholding Pattern
FIIFII increased stake by 86.51%
Bal Pharma stock performance
Open₹83.60
High₹84.45
Low₹81.10
Prev. close₹80.81
Bal Pharma trading activity
Volume14,478
Average traded price₹82.58
Last traded time03:23:33 03 Nov
Last traded quantity50
Circuit
L
H
₹76.77
₹84.85
52-week
L
H
₹60.00
₹124.60
Mkt Cap Cr
129.28
P/E
18.44
P/B
1.62
ROA
1.93%
ROE
7.64%
ROCE
9.18%
Quick Ratio
0.59
EV/EBITDA
7.97

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Bal Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Bal Pharma appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Bal Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Bal Pharma Company Background

ISIN
INE083D01012
Sector Market Cap
₹ 129.28 Cr

Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.

Bal Pharma Financial Highlights

  • Revenue: Bal Pharma reported revenue of ₹313.59 crore in FY26 vs ₹305.28 crore in FY25. It showed an increase of 2.72% on a yearly basis.
  • Operating Profit: Bal Pharma reported an operating profit of ₹5.93 crore in FY26 vs ₹5.14 crore in FY25. It showed an increase of 15.37% on a year-on-year basis.
  • Net Profit: Bal Pharma reported a net profit of ₹6.32 crore in FY26 vs ₹7.24 crore in FY25. It showed a decrease of 12.71% on a yearly basis.

Bal Pharma Quarterly Result Highlights

  • Bal Pharma reported revenue of ₹89.06 crore in Jun 2026, compared with ₹83.84 crore in Mar 2026, representing an increase of 6.23% on a quarter-on-quarter (QoQ) basis.
  • Bal Pharma reported an operating profit of ₹1.14 crore in Jun 2026, compared with ₹3.22 crore in Mar 2026, representing a decrease of 64.60% on a quarter-on-quarter (QoQ) basis.
  • Bal Pharma reported a profit of ₹1.14 crore in Jun 2026, compared with ₹3.60 crore in Mar 2026, reflecting a decrease of 68.33% on a QoQ basis.
  • The earnings per share (EPS) of Bal Pharma stood at ₹3.95 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
50.86%
FII
0.28%
Other DII
0.00%
Retail and other
48.87%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.14%
Mar 20260.14%
Jun 20260.15%
Sep 20260.28%

Bal Pharma Investment Returns

1 day
-1.27%
1 week
+2.16%
1 month
-23.58%
1 year
-1.99%
3 years
-8.64%
5 years
-16.82%

Bal Pharma Share Price History

Bal Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹81.50 / ₹80.81
-1.27%
30 Oct 26
₹84.05 / ₹81.85
-3.26%
29 Oct 26
₹86.50 / ₹84.61
-1.81%
28 Oct 26
₹83.00 / ₹86.17
+3.77%
Show more

Bal Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹311.66₹303.08₹339.22₹304.22
Other Income₹1.93₹2.20₹2.85₹0.94
Total Revenue₹313.59₹305.29₹342.07₹305.16
Total Expenses₹307.66₹300.15₹333.02₹300.41
Profit Before Tax₹5.93₹5.14₹9.05₹4.75
Tax-₹0.39-₹2.10₹1.60₹2.13
Profit After Tax₹6.32₹7.24₹7.45₹2.62
EPS - Basic₹3.95₹4.56₹4.96₹1.67
EPS - Diluted₹3.95₹4.56₹4.96₹1.68

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.93₹5.14₹9.05₹4.75
Income before WC changes₹32.47₹29.88₹31.39₹26.49
Change in Assets-₹29.37-₹11.84-₹3.06-₹65.63
Change in Liabilities₹27.73₹4.35-₹0.98₹38.11
Change in WC-₹1.64-₹7.49-₹4.04-₹27.53
Cash flow from Operations₹30.84₹20.31₹22.81-₹1.54
Cash flow from Investing-₹20.70-₹14.92-₹18.89-₹22.18
Cash flow from Financing-₹9.59-₹7.84-₹1.21₹24.09
Total Cash Flow₹0.55-₹2.44₹2.71₹0.37
Cash (Start of the year)₹1.75₹4.20₹1.49₹1.11
Cash (End of the year)₹2.30₹1.75₹4.20₹1.49

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹113.31₹100.82₹85.68₹85.02
Current Assets₹262.23₹234.87₹234.16₹228.16
Total Assets₹375.54₹335.69₹319.84₹313.17
Current Liabilities₹249.23₹219.50₹203.06₹209.33
Net Current Asset₹13.01₹15.37₹31.10₹18.82
Non-Current Liabilities₹44.06₹38.79₹44.81₹40.14
Equity Capital₹82.25₹77.40₹71.97₹63.70
Total Equity & Liabilities₹375.54₹335.69₹319.84₹313.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹310.80₹302.50₹338.54₹303.10
Other Income₹2.00₹2.15₹2.30₹2.19
Total Revenue₹312.80₹304.65₹340.84₹305.29
Total Expenses₹306.43₹298.91₹331.52₹296.74
Profit Before Tax₹6.37₹5.73₹9.32₹8.55
Tax-₹0.39-₹2.07₹1.59₹2.42
Profit After Tax₹6.75₹7.80₹7.73₹6.13
EPS - Basic₹4.51₹4.89₹5.13₹3.90
EPS - Diluted₹4.51₹4.89₹5.13₹3.94

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.37₹5.73₹9.32₹8.55
Income before WC changes₹32.88₹30.34₹30.85₹27.40
Change in Assets-₹29.66-₹12.58₹2.56-₹42.56
Change in Liabilities₹27.61₹4.63-₹0.32₹21.04
Change in WC-₹2.04-₹7.95₹2.23-₹21.52
Cash flow from Operations₹30.83₹20.31₹28.54₹5.38
Cash flow from Investing-₹20.69-₹14.90-₹18.84-₹22.08
Cash flow from Financing-₹9.58-₹7.83-₹6.94₹17.12
Total Cash Flow₹0.56-₹2.42₹2.76₹0.42
Cash (Start of the year)₹1.64₹4.06₹1.30₹0.81
Cash (End of the year)₹2.19₹1.64₹4.06₹1.23

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹115.42₹102.91₹87.68₹77.75
Current Assets₹275.64₹247.65₹246.55₹269.95
Total Assets₹391.06₹350.56₹334.23₹347.70
Current Liabilities₹243.30₹213.46₹197.13₹212.15
Net Current Asset₹32.33₹34.19₹49.41₹57.80
Non-Current Liabilities₹43.65₹38.28₹44.25₹39.52
Equity Capital₹104.10₹98.82₹92.84₹96.03
Total Equity & Liabilities₹391.06₹350.56₹334.23₹347.70
* All values are in INR Crore
Bal Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Bal Pharma technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
35.49
Neutral
ATR (14)
4.43
Neutral
STOCH(9,6)
25.89
Neutral
STOCH RSI (14)
31.25
Neutral
ADX(9)
33.35
Bearish
UO(9)
41.7
Neutral
ROC(12)
-17.91
Bearish
WillR(14)
-86.84
Bullish
Period
Simple value
Exponential vaue
5D
83.3
82.75
10D
84.02
85.2
20D
91.27
89.53
50D
95.04
92.52
100D
90.31
90.42
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Bal Pharma
Pharmaceuticals
Add Stock
Add Another

Bal Pharma Returns Calculator

Ex-date: 17 Sep 2026

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Bal Pharma Share Price FAQs

Please be aware that Bal Pharma stock prices are subject to continuous fluctuations due to various factors.